Literature DB >> 12023778

Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome.

Yuichi Nomura1, Masao Yoshinaga, Kiminori Masuda, Syuji Takei, Koichiro Miyata.   

Abstract

The symptoms of Kawasaki syndrome (KS) suggest a possible relationship between KS and superantigen(s). The infrequent occurrence of KS among young infants may be due to a passive maternal antibody. We investigated the antibody titers for superantigens (toxic shock syndrome toxin [TSST]-1, staphylococcal exotoxin B, and streptococcal pyrogenic exotoxins C and A) in 15 patients with KS who were <6 months of age prior to gamma globulin therapy and in 10 mothers of patients with KS <6 months of age. Significant findings were observed for only TSST-1 among the 4 anti-superantigens. The proportion of patients with KS who had high anti-TSST-1 titers was significantly higher than that among infant control subjects (33% vs. 5%, respectively; P=.031). The mean anti-TSST-1 titer for the mothers was significantly lower than that of adult control subjects (P=.021). Among infants <6 months of age, TSST-1 may be related to KS, and a maternal antibody may protect infants from developing KS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023778     DOI: 10.1086/340513

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Modelling seasonal variations in the age and incidence of Kawasaki disease to explore possible infectious aetiologies.

Authors:  Virginia E Pitzer; David Burgner; Cécile Viboud; Lone Simonsen; Viggo Andreasen; Claudia A Steiner; Marc Lipsitch
Journal:  Proc Biol Sci       Date:  2012-03-07       Impact factor: 5.349

Review 2.  Novel targeted immunotherapy approaches for staphylococcal infection.

Authors:  Michael Otto
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

3.  Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin.

Authors:  Noelia Moreno; Ana Méndez-Echevarría; Jaime de Inocencio; Fernando Del Castillo; Fernando Baquero-Artigao; María Jesús García-Miguel; María Isabel de José; Javier Aracil
Journal:  Pediatr Cardiol       Date:  2007-10-05       Impact factor: 1.655

4.  Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.

Authors:  K Matsubara; T Fukaya; K Miwa; N Shibayama; H Nigami; H Harigaya; H Nozaki; T Hirata; K Baba; T Suzuki; A Ishiguro
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

5.  Kawasaki disease after burns.

Authors:  Shuichi Ito; Masanori Anze; Akimichi Ishikawa; Yukoh Aihara; Shumpei Yokota
Journal:  Eur J Pediatr       Date:  2006-01-28       Impact factor: 3.183

6.  Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan.

Authors:  Xavier Rodó; Roger Curcoll; Marguerite Robinson; Joan Ballester; Jane C Burns; Daniel R Cayan; W Ian Lipkin; Brent L Williams; Mara Couto-Rodriguez; Yosikazu Nakamura; Ritei Uehara; Hiroshi Tanimoto; Josep-Anton Morguí
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

7.  The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?

Authors:  A R Porcalla; C A Sable; K M Patel; G R Martin; N Singh
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

8.  Neonatal Kawasaki disease: case report and data from nationwide survey in Japan.

Authors:  Mayumi Hangai; Yasuo Kubota; Jiro Kagawa; Mayumi Yashiro; Ritei Uehara; Yosikazu Nakamura; Masato Takeuchi
Journal:  Eur J Pediatr       Date:  2014-06-03       Impact factor: 3.183

Review 9.  An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureus.

Authors:  Prakash Narayana Reddy; Krupanidhi Srirama; Vijaya R Dirisala
Journal:  Infect Dis (Auckl)       Date:  2017-05-22

Review 10.  Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota.

Authors:  Kazunari Kaneko; Shohei Akagawa; Yuko Akagawa; Takahisa Kimata; Shoji Tsuji
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.